It is very uncertain whether cervical cerclage in combination with antibiotics and tocolytics changes preterm birth < 34 completed weeks of pregnancy compared with cervical cerclage alone (very low certainty).
It is very uncertain whether oxytocin solution changes need for treatment with antibiotics (infection) compared with expectant management (very low certainty).
Oxytocin solution showed no clear difference in need for treatment with antibiotics (infection) compared with saline solution (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether saline solution changes need for treatment with antibiotics (infection) compared with expectant management (very low certainty).
It is very uncertain whether routine antibiotic prophylaxis changes adverse effects of antibiotics (skin rash) compared with no treatment or placebo (very low certainty).
It is very uncertain whether antibiotic changes treatment failure compared with antibiotics during postpartum period (very low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal sepsis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).
Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) showed no clear difference in maternal endometritis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal wound infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal urinary tract infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).